S Kyriazi, DJ Collins, C Messiou, K Pennert… - Radiology, 2011 - radiology.rsna.org Materials and Methods: Research ethics committee approval and patient written informed consent were obtained. Diffusion-weighted (DW) magnetic resonance (MR) imaging was performed through the abdomen and pelvis before and after one and three cycles of chemotherapy in 42 ...
[HTML] from plos.orgMY Fong, J McDunn… - PloS one, 2011 - dx.plos.org In this study, we characterized the metabolome of the human ovary and identified metabolic alternations that coincide with primary epithelial ovarian cancer (EOC) and metastatic tumors resulting from primary ovarian cancer (MOC) using three analytical platforms: gas chromatography ... Related articles - Cached - All 3 versions
M Zillhardt, SM Park, IL Romero, K Sawada… - Clinical Cancer …, 2011 - AACR Purpose: Currently, there are no approved targeted therapies for the treatment of ovarian cancer, despite the fact that it is the most lethal gynecological malignancy. One proposed target is c-Met, which has been shown to be an important prognostic indicator in a number of ... Cited by 1 - Related articles - All 3 versions
J Chen, L Wang, LV Matyunina, CG Hill… - Gynecologic …, 2011 - Elsevier Ovarian cancer (OC) is the most lethal of all gynecological malignancies primarily due to the sloughing-off of highly metastatic cells from primary tumors and their subsequent spread throughout the peritoneal cavity. Since the epithelial-to-mesenchymal transition (EMT) of OC cells ... Related articles - All 2 versions
[PDF] from utoronto.caJ Dorn, N Harbeck, R Kates… - Annals of …, 2011 - Eur Soc Med Oncology Background: Primary tumor levels of serine proteases of the kallikrein-related peptidases (KLK) family as well as urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 impact disease course in ovarian cancer. The changes in levels of these factors from primary ... Cited by 3 - Related articles - All 6 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
